Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges

被引:0
作者
He, Yan-Fei [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 6, Dept Hlth Management Ctr, 6 Fucheng Rd, Beijing 100048, Peoples R China
关键词
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy; PORTAL-VEIN LIGATION; RADIOFREQUENCY ABLATION; HEPATIC RESECTION; SORAFENIB; CHEMOTHERAPY; BEVACIZUMAB; COMBINATION; EFFICACY; PLUS;
D O I
10.4251/wjgo.v16.i10.4289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, the World Journal of Gastrointestinal Oncology published an article entitled "Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of the literature", in which the authors shared their successful experience with complete surgical resection after multidisciplinary conversion therapy. The study by Chu et al demonstrates the great challenges that the advanced hepatocellular carcinoma (HCC) poses to surgical oncology, reveals the complexity of conversion therapy for unresectable HCC, emphasizes the important role of a multidisciplinary management model in conversion therapy, and enriches our understanding of the dynamics of personalized treatment for different patients. At present, conversion therapy is a hot research topic in the treatment of unresectable HCC, which has brought new hope to many patients with moderately advanced HCC. However, there are still many urgent problems to be solved in conversion therapy. Here, we would like to further discuss the advances and challenges of conversion therapy for unresectable HCC with the authors and the general readers.
引用
收藏
页码:4289 / 4297
页数:10
相关论文
共 50 条
[41]   Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma [J].
Tan, Bin-Bin ;
Fu, Ying ;
Shao, Ming-Hua ;
Chen, Hai-Lei ;
Liu, Ping ;
Fan, Chao ;
Zhang, Hui .
WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (09)
[42]   Therapeutic Strategies for Hepatocellular Carcinoma: New Advances and Challenges [J].
Sílvia Vilarinho ;
Tamar Taddei .
Current Treatment Options in Gastroenterology, 2015, 13 (2) :219-234
[43]   Efficacy of Surgical Microwave Therapy in Patients with Unresectable Hepatocellular Carcinoma [J].
Shinji Itoh ;
Yasuharu Ikeda ;
Hirofumi Kawanaka ;
Toshirou Okuyama ;
Katsumi Kawasaki ;
Daihiko Eguchi ;
Daisuke Korenaga ;
Kenji Takenaka .
Annals of Surgical Oncology, 2011, 18 :3650-3656
[44]   Safety and Survival Outcomes of Liver Resection following Triple Combination Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma [J].
Long, Yin ;
Huang, Jue ;
Liao, Jianguo ;
Zhang, Dongbo ;
Huang, Ziqi ;
He, Xiaodong ;
Zhang, Lei ;
Vitale, Alessandro ;
Midorikawa, Yutaka .
CANCERS, 2023, 15 (24)
[45]   Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma [J].
Podlasek, Anna ;
Abdulla, Maheeba ;
Broering, Dieter ;
Bzeizi, Khalid .
CANCERS, 2023, 15 (13)
[46]   Recent advances in recurrent hepatocellular carcinoma therapy [J].
Gao, Yu-Xue ;
Ning, Qi-Qi ;
Yang, Peng-Xiang ;
Guan, Yuan-Yue ;
Liu, Peng-Xiang ;
Liu, Meng-Lu ;
Qiao, Lu-Xin ;
Guo, Xiang-Hua ;
Yang, Tong-Wang ;
Chen, De-Xi .
WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) :460-476
[47]   Systemic Therapy for Hepatocellular Carcinoma: Advances and Hopes [J].
Zhang, Chen-Hao ;
Li, Ming ;
Lin, You-Pei ;
Gao, Qiang .
CURRENT GENE THERAPY, 2020, 20 (02) :84-99
[48]   Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis [J].
Liu, Kun ;
Zhu, Youwen ;
Zhu, Hong .
FRONTIERS IN IMMUNOLOGY, 2023, 13
[49]   Therapeutic advances for patients with intermediate hepatocellular carcinoma [J].
Sun, Jin-Yu ;
Yin, Tailang ;
Zhang, Xiao-Yu ;
Lu, Xiao-Jie .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) :12116-12121
[50]   Concurrent Sorafenib Therapy Extends the Interval to Subsequent TACE for Patients With Unresectable Hepatocellular Carcinoma [J].
Yao, Xuesong ;
Yan, Dong ;
Zeng, Huiying ;
Liu, Dengzhong ;
Li, Huai .
JOURNAL OF SURGICAL ONCOLOGY, 2016, 113 (06) :672-677